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1012-26 Degenerative Aortic Stenosis: An Arteriosclerotic 
Disease 
gery, when administred for just two days before surgery. 
Remy Chenevard, Markus Bechir, David, Georg Nell, Jurai Turina. University 
Hospital, Zurich, Switzerland 
Background Close relationship between degenerative aorlic stenosis (dAS) and arterio- 
sclerosis has been established recently, identifying dAS as an inflammatory disease. 
Indeed, local pathological changes at the stenotic aortic valve resemble closely arterio- 
sclerotic plaque. However, in almost half of the patients with dAS no sign of systemic 
arteriosclerosis is evident. 
Methods 16 patients with severe isolated dAS (mean transvalvular pressure gradient 56 
mmHg), angiographically normal coronaries and without clinical signs of peripheral artery 
disease were included. Flow mediated vasodilatation (FMD) was performed using high- 
resolution ultrasound. Results are expressed as percentage change from baseline. Nitro- 
glycerin (NG) sublingually served as marker for endothelium independent vasodilatation. 
Ultrasound and clinical assessment were repeated 3 months after aorlic valve replace- 
ment. Control subjects @IO) were matched for age, blood pressure, cholesterol and 
plasma glucose. 
Results Patients with dAS had significantly impaired FMD compared to the control 
group, yet there was no difference found before and after aortic valve replacement (1.7% 
+0.9 versus 3.4% 50.6. p<O.OOOl and 1.7% iO.9 versus 2.0% i1.0, ~~0.3 respectwely). 
Interestingly, NG induced vascdilatation was significantly decreased in dAS compared to 
the control group and was improved after valve replacement without reaching statistical 
significance (6.4% versus lO.l%, p=O.O4 and 6.4% versus 8.2%, p=O.Z). Climcal param- 
eters like blood pressure, lipids and plasma glucose remained unchanged throughout the 
study course. 
Conclusions Degenerative aortic stenosis in absence of manifest systemic arterioscle- 
rosis is associated with systemic endothelial dysfunction and reduced sensitivity to NG. 
These findings open the field for pharmacological restoration of endothelial function to 
slow progression of dAS. Aortic valve replacement by surgery does not seem to stop the 
systemic component of the disease. 
Methods: We did a randomised, double-blind placebo controlled trial in with patients 
undergoing coronary altery bypass graftmg (CABG) received amiodarone (n=46, aver- 
age age 61.0 years)or placebo (n=47. age 61,6 years). Patients were enrolled less than 
sixty hours before surgery and receveid 600mg PO three times daily. The mean preoper- 
ative total dose of amiodarone was 2.89. 
Results: Preoperative patient characteristics and procedure types were similar in both 
groups. Postoperative AFAF ocurred in 15,6% in the amiodarone group and 40.6% in the 
placebo group (P=O,Ol6). Incidence of complications other than AFAF were similar. 
Lenght of hospital stay for the placebo group was II,4 days, and 8,8 days for the amio- 
darone group (P=O,OE). No diference were noted in morality. 
Conclusions: Rapid load oral amiodarona was safe and effective in reducing the inci- 
dence of atrial fibrillation after CABG, but did not significantly alter lenght of hospital stay 
1037-23 Long-Term Results of the Surgical Treatment of Atrial 
Fibrillation: Predictors of Late Recurrence 
Svdnev L. Gavnor, Sunil Prasad, Richard B. Schuessler, Marci S. Bailey, John P. 
Boineau, Yosuke Ishii, Ralph J. Damiano. Jr., Washington University School of Medicine, 
St. Louis, MO 
Background: The Cox-Maze I (CM) procedure was introduced 15 years ago for the 
treatment of atrial fibrillation (AF). Smce then, 3 versions of this procedure have been 
performed, yet there has been no report comparing the long-term results of these differ- 
ent modifications. This study evaluates the results and predictors of AF recurrence in 259 
consecutive patients who undewent a CM procedure at our institution. Methods From 
1967 to 2002,259 patients (71 female and 188 male) underwent the CM procedure, with 
a mean age of 54*11 years. Thirty-two patients had CM I, 16 patients had CM II and 211 
patients had the CM Ill procedure. Data were analyzed by Cox-Regression analysis with 
pre- and post-operative variables used as covariates. Patient follow-up was conducted 
by questionnaire. physician examination, and electrocardiographic documentation. 
Result& The mean duration of preoperative AF was significantly longer in the CM I 
group as compared to CM II and Ill (p=O.O4). There was no difference in postoperative 
mortality between the groups. New pacemaker implantation was significantly higher in 
the CM I group. Patient follow-up was achieved in 90% of cases with a mean follow-up 
time of 5.9k3.5 years. The significant independent predictors of AF recurrence were 
duration of preoperative AF (p<O.OOl) and version of Maze (p=O.O2). Conclusion: The 
CM procedure remains the gold standard for the treatment of AF, and has evolved over 
time into a procedure with high long-term efficacy and a low incidence of complications. 
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1037-21 Prospective Multicenter Clinical Trial of Surgical 
Pulmonary Vein Isolation for the Treatment of Atrial 
Fibrillation 
Ralph J. Damiano. Jr., Patrick M. McCarthy, A M. Gillinov, William H. Ryan, Marc Ft. 
Moon, Michael J. Mack, Sydney L. Gaynor, Sunil Prasad, Samuel A. Wickline, Marci S. 
Bailey, Kara M. Barnett, Nicholas R. Damiano. Yosuke Ishii, Richard B. Schuessler, 
Washington University School of Medicine, Saint Louis, MO 
Background: The Cox-Maze (CM) procedure remains the gold standard for the surgical 
treatment of atrial fibrillation (AF). However, the original ‘“cut and sew technique” is time 
consuming and technically challenging. We have modified the CM Ill procedure by using 
a bipolar radiofrequency (RF) ablative device to isolate the pulmonary veins (PV). The 
other lesions of the CM procedure were performed either with RF or incisions. The pur- 
pose of this multicenter trial was to demonstrate the efficacy and safety of bipolar RF in 
isolating the PV and replacing the surgical incisions of the Cox-Maze procedure. 
Methods: Beginning January 2002, 26 consecutive patients (9 female, 17 male) under- 
went PV isolation utilizing RF at three medical centers. Mean age was 60.12 12.2 years. 
Seventeen patients had paroxysmal AF while 9 had chronic AF with a a mean AF dura- 
tion of 7.6 + 6.9 years. Electrical isolation of the PV was documented with intraoperative 
pacing in all patients. Atrial function and PV patency were assessed by post-operative 
MRI or 3D computed tomography at 1 month. 
Results: The left ILPV) and riaht fRPVI ~ulmonaw vems were isolated in evew instance. 
The LPV underwent 3.b _c 1 .i Ri ap&ations while the RPV underwent 2.8 + 1 .O RF 
aDDlications. Ablation times were 26.4 + 10.4 seconds for the LPV and 27.4+ 13.1 sec- 
onds for the RPV. There were no operative mortalities. Follow-up MRI showed preserved 
atrial contractility and no evidence of significant PV stenosis. At last follow-up, 24 of 26 
patients (92%) were in sinus rhythm and two patients were in atrial fibrillation. 
Conclusions: Bipolar RF ablation can be used effectively and safely to isolate the PV, 
replacing the “cut and sew” technique. This technology has the potential to simplify the 
surgical treatment of AF. 
1037-22 Rapid Load Oral Amiodarone Reduces Incidence of 
Postoperative Atrial Fibrillation and Atrial Flutter 
Rafael V. Akalde, Luiz C. Bodanese, Iran Castro, Jolo B. Petracco, Eliana Sussenbach, 
Roberta Noer. Jo&z Carlos V. Guaragna, Hospital SBo Lucas da PUCRS, Porlo Alegre, 
Brazil, lnstituto de Cardiologia do RGS, Port0 Alegre, Brazil 
Background: Atrial Fibrillation and Atrial Flutter (AFAF) are a common occurence after 
heart operations that use cardiopulmonary bypass. Some studies have demonstrated 
that amiodarone reduce incidence of AFAF after open heart surgery. This study was 
designed to evaluate the effect of amiodarona on the prevention AFAF after bypass sur- 
March 19,2003 
Summary: 
Number Duration New Operative Freedom from Actuarial 10 
of of AF Pacemak Mortality AF(%atlO yr survival 
patients (yrs) er (%) (%) yrs) (%) 
Maze1 32 lO.E-t9.8 53 0 69 92 
Mazell 16 5.9i5.2 25 6.2 85 93 
Maze III 211 7.7zt7.5 15 1.4 94 94 
p-value 0.04 <O.OOl 0.24 0.02 0.5 
(CM I vs 
CM Ill) 
1037-24 Does the Cox-Maze Procedure Impact Quality of Life in 
the Late Postoperative Period? 
Cindv J. Camille, Marc R. Moon, Richard B. Schuessler, John P. Boineau, Ralph J. 
Damiano. Jr., Washington University, St. Louis, MO 
Background: A common indication for surgical treatment of chronic atrial fibrillation is the 
negative impact of the disease on the patient’s quality of life (QOL). However, the influ- 
ence of the Cox-Maze procedure on QOL in the late postoperative period remains 
unclear. Methods: Over a 10 year period, 199 patients underwent the &x-Maze proce- 
dure for persistent (120, 60%) or permanent (79, 40%) atrial fibrillation. Indications for 
surgery included arrhythmia or drug intolerance (76%) or thromboembolic events (24%). 
The mean (* SD) age was 52 t II years and there were 155 (78%) men. A lone Cox- 
Maze procedure was performed in 132 (66%), while 67 (34%) underwent a concomitant 
procedure (CABG. valve, or ASD closure). Complete QOL assessment was performed in 
102 patients using two standard survey tools: the Medical Outcomes SF-36 (100 point 
scale) and the Ferrans and Powers QOL Index (30 point scale). Results: Mean follow-up 
was 64 f 25 months postoperatively. The average score across all 8 domains of the SF- 
36 was 73 * 28 for Maze patients. which was not significantly different than the age- 
adjusted US norm (72 * 27) for the general population (p>0.79). Comparing lone Maze 
versus concomitant Maze patients, there was no difference in SF-36 (p>0.67) or QOL 
Index (p>O.99). In addition, age did not Impact either SF-36 (p>O.74) or QOL Index 
(p>O.21). However, males had significantly higher QOL scores than females (SF-36: 76 * 
24 vs. 64 + 29, p<O.O02; QOL Index: 24 * 4 vs. 22 f 4, pcO.02). Conclusion: Compared 
to the general population, patients who have undergone the Cox-Maze procedure have a 
stmilar level of satisfaction with their QOL. In addition, while age had no impact, males 
had a significantly higher QOL than females. The Cox-Maze procedure returns patients 
to a normal QOL and should be considered for those who are intolerant of their arrhyth- 
mia. 
